Cost-Effectiveness Analysis Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Cost-Effectiveness Analysis. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cost-Effectiveness Analysis Indian Medical PG Question 1: Which intervention has shown the highest return on investment in national STI control programs?
- A. Mobile testing units
- B. Online partner notification
- C. Integration with HIV services (Correct Answer)
- D. Mass media campaigns
Cost-Effectiveness Analysis Explanation: ***Integration with HIV services***
- This approach offers the **highest return on investment** for national STI control programs as it leverages existing infrastructure and funding for HIV services, maximizing resource utilization.
- **Syndromic management of STIs integrated with HIV care** allows for efficient screening, diagnosis, and treatment of both conditions simultaneously, reaching high-risk populations effectively.
- **India's National AIDS Control Programme (NACP)** successfully demonstrates this model, with STI/RTI services integrated into HIV testing and counseling centers, reducing duplication and operational costs.
- **WHO guidelines strongly recommend** this integration strategy as the most cost-effective approach for national STI control programs, particularly in resource-limited settings.
*Mobile testing units*
- While helpful for reaching underserved populations, **mobile units have high operational costs** including staffing, vehicle maintenance, and equipment, which significantly limit their overall return on investment.
- Their effectiveness is often localized and may not provide broad, sustainable impact across an entire national program compared to integrated services.
*Online partner notification*
- This method's reach is limited by **digital literacy and access barriers**, potentially excluding high-risk groups without internet access, particularly relevant in the Indian context.
- While it can improve partner tracing in certain populations, the initial setup costs and limited universal applicability reduce its overall cost-effectiveness compared to integrated clinical services.
*Mass media campaigns*
- These campaigns require **significant financial investment** for broadcast time and creative development, with outcomes that are difficult to quantify in terms of direct STI reduction.
- While effective for raising general awareness, they generate less measurable return on investment for direct STI control services compared to targeted clinical interventions like integrated service delivery.
Cost-Effectiveness Analysis Indian Medical PG Question 2: For evaluating the functioning of a health center, which is the most important determinant for assessing clinical management?
- A. Structure
- B. Input
- C. Process (Correct Answer)
- D. Outcome
- E. Output
Cost-Effectiveness Analysis Explanation: ***Process***
- Evaluating the **process** involves assessing the actual delivery of care, including adherence to clinical guidelines, patient-provider interactions, and the timeliness and appropriateness of services. This directly reflects the quality of **clinical management**.
- It focuses on *how* care is provided, which is crucial for identifying areas of strength and weakness in the day-to-day operations of a health center's clinical functions.
*Structure*
- **Structure** refers to the resources and settings in which care is provided, such as facilities, equipment, staff qualifications, and organizational policies.
- While important, a good structure does not guarantee good clinical management; the structure offers the potential for quality, but the actual delivery of care (process) is what matters most for assessment.
*Input*
- **Input** is a broad term often overlapping with structure, referring to the resources poured into the system like funding, staff, and materials.
- Like structure, input provides the necessary components, but evaluating them alone does not directly assess the *effectiveness* or *quality* of clinical management.
*Output*
- **Output** refers to the immediate results of service delivery, such as the number of patients seen, procedures performed, or services rendered.
- While outputs can be measured, they represent quantity rather than quality and do not directly assess the appropriateness or effectiveness of clinical management itself.
*Outcome*
- **Outcome** measures the end results of care, such as patient health status, satisfaction, or mortality rates.
- While outcomes are critical, they are often influenced by many factors beyond direct clinical management (e.g., patient adherence, social determinants of health) and may not immediately reflect the quality of the *process* of care delivery itself.
Cost-Effectiveness Analysis Indian Medical PG Question 3: Disability-adjusted life years (DALYs) measure the burden of disease by accounting for both:
- A. None of the options
- B. Morbidity and disability
- C. Mortality and disability (Correct Answer)
- D. Morbidity and mortality
Cost-Effectiveness Analysis Explanation: ***Mortality and disability***
- **DALYs** quantify the overall burden of disease by combining years of life lost due to **premature mortality** and years lived with disability.
- This metric provides a comprehensive measure of disease impact, reflecting both the fatal and non-fatal consequences of illness.
*Morbidity and disability*
- While both **morbidity** (illness) and **disability** contribute to disease burden, DALYs specifically quantify the years lived with disability, not just the general state of morbidity.
- **Morbidity** is a broader term encompassing any illness or disease, which doesn't fully capture the "years lost" component of DALYs.
*None of the options*
- This option is incorrect because **DALYs** are explicitly defined by the combination of mortality and disability.
- The definition of **DALYs** is standard in public health and epidemiology.
*Morbidity and mortality*
- Although both **morbidity** and **mortality** are crucial aspects of population health, DALYs use **disability** (specifically "years lived with disability" or YLDs) in conjunction with **mortality** ("years of life lost" or YLLs).
- Simply using "morbidity" is less precise than "disability" when defining the components of DALYs.
Cost-Effectiveness Analysis Indian Medical PG Question 4: Which of the following statements is TRUE regarding Disability-Adjusted Life Year (DALY)?
- A. Years lost due to disability (YLD) are not considered in DALY.
- B. DALY only measures mortality and does not include morbidity.
- C. DALY does not account for both YLD and YLL.
- D. DALY includes both Years of Life Lost (YLL) and Years Lived with Disability (YLD). (Correct Answer)
Cost-Effectiveness Analysis Explanation: ***DALY includes both Years of Life Lost (YLL) and Years Lived with Disability (YLD).***
- This statement is **correct**. The fundamental formula is **DALY = YLL + YLD**.
- **YLL (Years of Life Lost)** quantifies the burden of premature mortality by measuring years of potential life lost due to early death.
- **YLD (Years Lived with Disability)** quantifies the burden of morbidity by measuring time lived in states of less than full health.
- **DALY** is a comprehensive health metric designed to capture the total burden of disease by integrating both mortality and morbidity components.
- This unified metric allows comparison of disease burden across different conditions and populations.
*Years of Life Lost (YLL) is not included in DALY calculations.*
- This is **incorrect**. YLL is a core component of DALY calculations, representing the mortality burden.
*Years lost due to disability (YLD) are not considered in DALY.*
- This is **incorrect**. YLD is an essential component of DALY, representing the morbidity burden.
*DALY only measures mortality and does not include morbidity.*
- This is **incorrect**. DALY explicitly measures both mortality (through YLL) and morbidity (through YLD), making it a comprehensive burden of disease measure.
Cost-Effectiveness Analysis Indian Medical PG Question 5: The most comprehensive indicator of cost-effectiveness analysis is
- A. Number of heart attacks avoided
- B. Cost per life year gained
- C. Number of life years gained
- D. QALYs gained (Correct Answer)
Cost-Effectiveness Analysis Explanation: ***QALYs gained***
- **Quality-Adjusted Life Years (QALYs)** is the most comprehensive measure in cost-effectiveness analysis as it accounts for both the quantity and quality of life
- Combines years of life added with a utility score reflecting health-related quality of life during those years
- Provides a holistic view that captures both mortality and morbidity benefits of interventions
*Number of heart attacks avoided*
- Specific to a single clinical outcome and does not account for other health benefits or adverse effects
- While important for cardiovascular interventions, it is too narrow to serve as a comprehensive cost-effectiveness indicator
- Does not capture broader impact on overall health, quality of life, or longevity
*Cost per life year gained*
- Focuses on the quantity (length) of life gained but does not consider the quality of those gained years
- An intervention might add years of life that are of poor quality, which this measure cannot differentiate
- Less comprehensive than QALYs as it misses the health status dimension
*Number of life years gained*
- Only considers the extension of life without incorporating health status or quality of life during additional years
- Provides an incomplete picture as it treats all life years equally regardless of health state
- A longer life with significant disability would be valued the same as healthy years
Cost-Effectiveness Analysis Indian Medical PG Question 6: Which of the following evaluation methods primarily involves monetary terms?
- A. Cost benefit analysis (Correct Answer)
- B. Network analysis
- C. Cost minimization analysis
- D. All of the options
Cost-Effectiveness Analysis Explanation: ***Cost benefit analysis***
- This method evaluates both the **costs** and **benefits** of a project or intervention in **monetary terms**.
- It is the **only economic evaluation method** that expresses **both costs AND outcomes (benefits) in monetary units**.
- This allows for a direct comparison of the financial value of benefits against the financial value of costs to determine overall worth and calculate net benefit or benefit-cost ratio.
*Network analysis*
- **Network analysis** is a quantitative method that focuses on relationships or connections between entities.
- It is primarily used for understanding **structures and patterns** in complex systems (like disease transmission networks), not for direct monetary valuation.
- This is **not an economic evaluation method**.
*Cost minimization analysis*
- This method compares only the **costs** of two or more interventions that are proven to have **equivalent outcomes or effectiveness**.
- While it deals with costs in monetary terms, it **does not express benefits/outcomes in monetary units** - it simply assumes they are equal.
- The primary goal is to identify the **least expensive option** among equally effective alternatives, not to monetize outcomes.
Cost-Effectiveness Analysis Indian Medical PG Question 7: In which of the following methods of management is the benefit measured in natural units?
- A. Network analysis
- B. Cost-benefit analysis
- C. Program budgeting system
- D. Cost-effectiveness analysis (Correct Answer)
Cost-Effectiveness Analysis Explanation: ***Cost-effectiveness analysis***
- In **cost-effectiveness analysis**, the benefits of a healthcare intervention are measured in **natural units** (e.g., lives saved, years of life gained, cases cured, reduction in symptoms).
- This method compares the costs of different interventions to achieve a specific health outcome, expressed in a non-monetary unit.
*Network analysis*
- **Network analysis** is a project management technique used to plan and control complex projects, often for scheduling tasks and identifying critical paths.
- Its primary focus is on task dependencies and timelines, not on measuring benefits of management interventions in natural units.
*Cost-benefit analysis*
- In **cost-benefit analysis**, both the costs and the benefits of an intervention are converted into **monetary units**.
- This allows for a comparison where a project is deemed beneficial if its monetary benefits outweigh its monetary costs.
*Program budgeting system*
- A **program budgeting system** is a financial planning and management tool that links expenditures to the achievement of specific program objectives.
- While it focuses on resource allocation and outcomes, it does not primarily measure benefits in natural health units.
Cost-Effectiveness Analysis Indian Medical PG Question 8: What is the most cost-effective screening strategy for STIs in resource-limited settings according to WHO guidelines?
- A. Risk-based screening
- B. Periodic mass treatment
- C. Syndromic management (Correct Answer)
- D. Universal screening
Cost-Effectiveness Analysis Explanation: ***Syndromic management***
- This approach involves diagnosing and treating STIs based on the **clinical symptoms** presented by the patient, without the need for expensive laboratory tests.
- It is highly cost-effective in resource-limited settings as it reduces the need for costly diagnostics while ensuring prompt treatment to prevent complications and onward transmission.
*Risk-based screening*
- While helpful, identifying high-risk individuals and conducting targeted screening still requires some level of diagnostic testing, which can be **expensive** or **unavailable** in resource-limited settings.
- It may miss STIs in individuals who do not fit predefined risk categories but are still infected.
*Periodic mass treatment*
- This strategy involves treating a large population group for STIs regardless of their symptom status, which can lead to **antimicrobial resistance** and is not specifically recommended by WHO for routine STI control.
- It is generally **inefficient** and potentially wasteful of resources, as many individuals treated may not be infected.
*Universal screening*
- This approach involves comprehensive diagnostic testing for all individuals, which is highly effective but **prohibitively expensive** and logistically challenging for resource-limited settings.
- It requires significant infrastructure for laboratory testing and follow-up, which is often lacking where resources are scarce.
Cost-Effectiveness Analysis Indian Medical PG Question 9: Which analysis method categorizes items based on their expenditure, identifying a small number of high-value items and a large number of low-value items?
- A. ABC analysis (Correct Answer)
- B. SUS analysis
- C. HML analysis
- D. VED analysis
Cost-Effectiveness Analysis Explanation: ***ABC analysis***
- **ABC analysis** classifies inventory items into three categories (A, B, and C) based on their annual consumption value, identifying a small percentage of items that account for most of the expenditure.
- **Category A** items are high-value and high-priority (typically 10-20% of items accounting for 70-80% of expenditure), while **Category C** items are low-value and low-priority (50-70% of items accounting for 5-10% of expenditure), fitting the description of a small number of high-value items and a large number of low-value items.
- Based on the **Pareto principle (80/20 rule)** in inventory management.
*SUS analysis*
- **SUS analysis** categorizes items based on their **procurement characteristics**: **Scarce** (difficult to procure), **Urgent** (needed immediately), and **Seasonal** (required at specific times).
- It focuses on availability and timing of procurement rather than expenditure or consumption value.
- Does not classify items by their monetary value or identify high vs. low-value items.
*HML analysis*
- **HML analysis** categorizes items based on their **unit price** (High, Medium, Low), not their total expenditure or annual consumption value.
- While it considers value, it doesn't prioritize items by the total financial impact or identify the expenditure pattern described in the question.
*VED analysis*
- **VED analysis** classifies inventory items based on their **criticality** (Vital, Essential, Desirable) for operational needs, particularly in healthcare where stockouts can have severe consequences.
- It focuses on the importance of an item for function and patient care, rather than its monetary expenditure or value.
Cost-Effectiveness Analysis Indian Medical PG Question 10: What is the effect of increasing the confidence level in hypothesis testing?
- A. Previously significant value remains significant
- B. Hypothesis testing outcome may change
- C. Increased significance threshold affects results (Correct Answer)
- D. Previously insignificant value may become significant
Cost-Effectiveness Analysis Explanation: ***Increased significance threshold affects results***
- Increasing the **confidence level** (e.g., from 95% to 99%) means we are demanding higher certainty that our result is not due to random chance. This translates to a **lower alpha (significance level)** - from α=0.05 to α=0.01.
- A higher confidence level implies a **more stringent threshold** for rejecting the null hypothesis. The p-value must now be smaller than the reduced alpha to achieve statistical significance.
- This makes it **harder to reject the null hypothesis** and reduces the probability of Type I error (false positive).
*Previously significant value remains significant*
- This statement is incorrect because if a **p-value** was barely significant at a lower confidence level (e.g., p=0.04 at 95% confidence, α=0.05), it would become **non-significant** at a higher confidence level (e.g., 99% confidence, α=0.01).
- The threshold for **statistical significance** becomes stricter, meaning fewer results will meet the criteria.
*Hypothesis testing outcome may change*
- While this is technically true, it is less precise than the correct answer. The outcome may change specifically because results that were previously significant may become non-significant.
- This option describes a **consequence** rather than the direct effect of changing the confidence level.
*Previously insignificant value may become significant*
- This statement is incorrect. If a result was **non-significant** at a lower confidence level (e.g., p=0.06 at 95% confidence, α=0.05), it will certainly remain non-significant at a higher confidence level (e.g., 99% confidence, α=0.01).
- Increasing the confidence level makes it **harder, not easier** to achieve statistical significance by requiring a smaller p-value to reject the null hypothesis.
More Cost-Effectiveness Analysis Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
